Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
U.S. weight-loss stock concepts rose, with Eli Lilly climbing more than 4% to hit a record high, Amgen up over 3%, and Novo Nordisk and Pfizer each up more than 1%.
U.S. weight-loss stock concepts rose, with Eli Lilly climbing more than 4% to hit a record high, Amgen up over 3%, and Novo Nordisk and Pfizer each up more than 1%.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report



